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ABSTRACT
Objective: The objective of this study is to assess the quality of life (QOL) using the Diabetes-39 (D-39) questionnaire in the patients of Type 2 
diabetes mellitus (DM).
Methods: A cross-sectional study was performed in the outpatient department (OPD). The study population was consisted of 160 Type 2 DM patients 
attending the OPD. This study was carried out for 3 months.
Results: Our study showed a total of 93 males (58.13%) and 67 females (41.88%). Mean age in our study was 48.72±8.17 years. Mean duration of 
diabetes in our study was 5±3.06 years. Our study shows that 61 (38.12%) has hypertension as a comorbidity, 28 (17.5%) has hyperlipidemia, and 
2 (1.25%) has renal dysfunction. The D-39 instrument evaluation containing five dimensions: Energy and mobility (15 items), diabetes control (12), 
anxiety and worry (4), social overload (5), and sexual behavior (3) were used.
Conclusion: This study demonstrated that the QOL in patients of diabetes is clearly affected by the complication and comorbidities associated with 
Type 2 diabetes. Longer studies are needed to completely assess the QOL.
Keywords: Type 2 diabetes mellitus, Quality of life, Diabetes-39 questionnaire.
INTRODUCTION
Diabetes is a disease of paramount public health concern. Worldwide, 
an estimated 422 million adults were suffering from diabetes in 2014; 
also it caused 1.5 million deaths in 2012. For the past decades, the 
prevalence of diabetes has been ascended more in low- and middle-
income countries [1]. Nearly, three-quarter of the people with diabetes 
reside in low- and middle-income countries. In India, there were nearly 
61 million patients with Type 2 diabetes mellitus (DM), in 2011, which 
will rise to 101 million by 2030 [2].
Diabetes in long run cause many problems in the body which could 
be microvascular as well as macrovascular as cardiac problem, renal 
failure, poor vision, nerve damage, poor wound healing, etc., that in turn 
increase the risk of morbidity and mortality also remarkably hamper 
quality of life (QOL) of the patient [1,3]. The World Health Organization 
defines QOL as an individual’s perception of their position in life in 
the context of the culture and value systems, in which they live and in 
relation to their goals, expectations, standards, and concerns [4].
Diabetes and its complications cause considerable financial deficit 
to patients and their families, and to health systems and national 
economies through direct medicinal expenses and loss of employment 
and income [1]. Lack of proper compliance and management of diabetes 
has an adverse effect on glycemic control. Patients with controlled 
diabetes have superior QOL as compare to uncontrolled diabetic 
patients [5].
Diabetes is a chronic health situation causes grave constraints on 
patient’s performance. There is a call for education and behavior 
change to deal with the situation. Lifestyle changes have to fit in careful 
dietary scheduling, compliance of medication, and home blood glucose 
monitoring for all diabetic patients [6]. The attainment of information 
about the disease is acknowledged as a significant aspect lead to 
enhancement in self-care behavior [5].
The diabetes-39 (D-39) instrument evaluation containing five 
dimensions: Energy and mobility (15 items), diabetes control (12), 
anxiety and worry (4), social overload (5), and sexual behavior (3) were 
used to assess the QOL in Type 2 diabetic patients.
METHODS
A cross-sectional study was performed in the Outpatient Department 
(OPD) of Medicine in Gandhi Medical College, Bhopal. The study 
population was consisted of 160 Type 2 DM patients attending the OPD. 
This study was carried out for 3 months. This study was carried out in 
patients over the age of 18 years and who gave consent to participate 
in the study.
To obtain the information of the study population, a form was provided 
to which included the sociodemographic data such as age, sex, duration 
of diabetes, weather they live in rural or urban area, comorbidities if 
any present, and if diabetes is present in immediate family members. 
The second form was the D-39 assessment questionnaire which 
was translated into the local language if needed for the participants. 
This instrument was used as it was easy to administer and easy to 
understand, and it was based on Likert scale, which uses a 7 point 
category as ”unaffected” and “very much affected” as the highest and 
the lowest values, based on previous research [7]. Results will be 
analyzed by excel software.
RESULTS
It was noted that in terms of demography of the population, there were 
93 males (58.13%) and 67 females (41.88%) (Fig. 1). Mean age in our 
study was 48.72±8.17 years. Mean duration of diabetes in our study 
was 5±3.06 years.
Our study shows that 61 (38.12%) has hypertension as a comorbidity, 
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Out of the total diabetic patients attended the OPD, a total of 88 (55%) 
has one member in the family as diabetic, 34 (21.25%) patients has 
2 members in their family as diabetic, and 38 (23.75%) patients has 
none of the family members diagnosed a diabetic. Of the total study 
population who attended the OPD, 62 (38.75%) lives in urban area and 
98 (61.25%) lives in rural area.
Table 1 shows that the distribution of patients diagnosed with Type 2 
DM according to the responses of the D-39 questionnaire, which is 
divided into five dimensions. In column 1 and column 7, the highest 
and the lowest values being marked can be seen, the values above 50% 
being considered significant.
In relation to energy and mobility, dimension of the D-39 questionnaire 
(Items 3, 7, 9, 10, 11, 12, 13, 16, 25, 29, 32, 33, 34, 35, and 36).
In relation to energy and mobility, dimension 1 of the D-39 questionnaire, 
none of the values were significant. Although the question 9, feeling of 
weakness 31.88% patients were least affected, whereas question 13. Not 
being able to do what you want, 23.75% were also least affected. The rest 
of the questions in dimension 1 were in a range of 7.50-31.88%, while 
question 29 had an even distribution across the table. Question 12; loss 
or blurring of vision; 23.75% were severely affected.
Dimension 2; diabetes control question 4, 46.25% were not affected, 
whereas only 0.63% were severely affected. While in question 1; 
36.88% patients were not affected and were not significant. Overall in 
dimension 2, the percentage in the least affected was in the range from 
5.63% to 46.25% which were insignificant, whereas it ranged from 
0.63% to 15.63% who were more affected in the questions described in 
the dimension 2 of the D-39 questionnaire.
Dimension 3; anxiety and worry, question 6, concerns about your 
future, the maximum score was 28.75% who were least affected and 
18.12% were greatly affected. Overall, the score was 3.13-25% in all the 
questions in dimension 3 who were least affected, whereas it ranged 
from 5.62% to 18.12% in more severely affected patients.
Dimension 4, all the criteria were not significant, with the percentage 
ranging from 5% to 11.25% who were least affected in the questions 
of dimension 4, whereas it ranged from 9.38% to 12.50%, who were 
severely affected.
Dimension 5, sexual behavior, 35% of the patients in problems with 
sexual functioning were least affected, whereas only 5% patients had 
difficulty, rest all the dimension were not significant overall.
Table 2 indicates the general evaluation of life. Overall QOL shows that 
only 15% patients were severely affected and 8.75% patients were least 
affected, while for question; How severe you think your diabetes is?; 
indicates that a total of 19.38% patients were severely affected and 
9.38% patients were least affected.
DISCUSSION
This study was done to assess, the overall QOL in patients of Type 2 
diabetes using the D-39 questionnaire. It is an easy understanding that 
Fig. 1: Age-wise distribution of patients
Fig. 2: Comorbidities
Items N (%)
1 2 3 4 5 6 7
First dimension: Energy and mobility
3. Limited energy levels 34 (21.25) 43 (26.88) 15 (9.38) 21 (13.13) 27 (16.88) 12 (7.50) 8 (5.0)
7. Other health problems besides diabetes 16 (10.0) 23 (14.38) 26 (16.25) 29 (18.13) 34 (21.25) 22 (13.75) 10 (6.25)
9. Feelings of weakness 51 (31.88) 11 (6.88) 28 (17.50) 20 (12.50) 23 (14.38) 13 (8.13) 14 (8.75)
10. Restrictions on how far you can walk 25 (15.63) 19 (11.88) 24 (15.0) 15 (9.38) 18 (11.25) 41 (25.63) 18 (11.25)
11. Any daily exercises for your diabetes 20 (12.50) 27 (16.88) 22 (13.75) 27 (16.88) 28 (17.50) 21 (13.13) 15 (9.38)
12. Loss or blurring of vision 30 (18.75) 43 (26.88) 20 (12.50) 12 (7.50) 9 (5.63) 8 (5) 38 (23.75)
13. Not being able to do what you want 38 (23.75) 18 (11.25) 20 (12.50) 28 (17.50) 16 (10.0) 28 (17.50) 12 (7.5)
16. Other health problems besides diabetes 16 (10.0) 23 (14.38) 26 (16.25) 29 (18.13) 34 (51.25) 22 (13.75) 10 (6.25)
25. Other illnesses besides diabetes 14 (8.75) 20 (12.50) 22 (13.75) 26 (16.25) 36 (22.50) 27 (16.88) 15 (9.38)
29. Complications from your diabetes 29 (18.13) 21 (13.13) 22 (13.75) 23 (14.38) 28 (17.50) 20 (12.50) 17 (10.63)
29.  Not being able to do housework or other 
jobs around the house
15 (9.38) 24 (15.0) 23 (14.38) 21 (13.13) 32 (20.0) 32 (20.0) 13 (8.13)
32. Needing to rest often 16 (10.0) 23 (14.38) 23 (14.38) 24 (15.0) 41 (25.63) 26 (16.25) 7 (4.38)
33.  Problems in climbing stairs or walking up 
steps
29 (18.13) 30 (18.75) 24 (15.0) 26 (16.25) 24 (15.0) 15 (9.38) 12 (7.5)
34. Having trouble caring for yourself 16 (10.0) 22 (13.75) 22 (13.75) 28 (17.50) 25 (15.63) 32 (20.0) 15 (9.38)
35. Restless sleep 12 (7.50) 21 (13.13) 21 (13.13) 23 (14.38) 38 (23.75) 29 (18.13) 16 (10.0)
36. Walking more slowly than others 16 (10.0) 22 (13.75) 20 (12.50) 25 (15.63) 44 (27.50) 25 (15.63) 8 (5.0)
Second dimension diabetes control
1. Your diabetes medication schedule 59 (36.88) 28 (17.5) 8 (5.0) 22 (13.75) 17 (10.62) 13 (8.12) 13 (8.12)
Table 1: Percentage distribution of patients with DM according to the responses to the items of the five dimensions of the D‑39
(Contd...)
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the older patients were severely affected by the comorbidities and the 
complications of Type 2 diabetes. Similar studies should be carried out 
in different locations so that we have a better understanding of the QOL 
in patients and a better patient education system can be included. This 
study has its limitations, which include that it was only carried out for 
3 months, and it was single-centric study. A lengthier study should be 
carried out so that a better understanding of the QOL can be assessed 
and more detailed analysis can be done.
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Table 2: General evaluation of life
Items N (%)
1 2 3 4 5 6 7
Overall QOL 14 (8.75) 13 (8.13) 31 (19.38) 34 (21.25) 25 (15.63) 19 (11.88) 24 (15.00)
How severe you think your diabetes is? 15 (9.38) 20 (12.50) 22 (13.75) 20 (12.50) 27 (16.88) 25 (15.63) 31 (19.38)
QOL: Quality of life
Items N (%)
1 2 3 4 5 6 7
4.  Following your doctor’s prescribed 
treatment plan for diabetes
74 (46.25) 19 (11.88) 16 (10.0) 24 (15.0) 17 (10.63) 9 (5.63) 1 (0.63)
5.  Food restrictions required to control your 
diabetes
22 (13.75) 15 (9.38) 22 (13.75) 26 (16.25) 20 (12.50) 32 (20.0) 23 (14.38)
14. Having diabetes 19 (11.88) 25 (15.63) 27 (16.88) 24 (15.0) 22 (13.75) 27 (16.88) 16 (10.0)
15. Losing control of your blood sugar levels 27 (16.88) 15 (9.38) 20 (12.50) 22 (13.75) 25 (15.63) 26 (16.25) 25 (15.63)
17. Testing your blood sugar levels 24 (15.0) 20 (12.50) 25 (15.63) 16 (10.0) 20 (12.50) 39 (24.38) 16 (10.0)
18. The time required to control your diabetes 52 (32.50) 27 (16.88) 21 (13.13) 21 (13.13) 18 (11.25) 11 (6.88) 10 (6.25)
24. Getting your diabetes well controlled 14 (8.75) 18 (11.25) 21 (13.13) 27 (16.88) 45 (28.13) 28 (17.50) 7 (4.38)
27. Keeping a record of your blood sugar levels 15 (9.38) 19 (11.38) 21 (13.13) 26 (16.25) 28 (17.50) 27 (16.88) 24 (15.0)
28. The need to eat at regular intervals 24 (15.0) 17 (10.63) 17 (10.63) 27 (16.88) 35 (21.88) 22 (13.75) 18 (11.25)
31.  Having to organize your daily life around 
diabetes
9 (5.63) 16 (10.0) 20 (12.5) 31 (19.38) 41 (25.63) 26 (16.25) 17 (10.63)
39. Diabetes in general 13 (8.13) 17 (10.63) 20 (12.50) 30 (18.75) 28 (17.50) 27 (16.88) 25 (15.63)
Third dimension: Anxiety and worry
2. Worries about money matters 40 (25.0) 36 (22.5) 16 (10.0) 18 (11.25) 28 (17.5) 13 (8.12) 9 (5.62)
6. Concerns about your future 46 (28.75) 4 (2.5) 10 (6.25) 26 (16.25) 23 (14.37) 23 (14.37) 29 (18.12)
8. Stress or pressure in your life 5 (3.13) 12 (7.50) 22 (13.75) 37 (23.13) 45 (28.13) 25 (15.63) 14 (8.75)
22. Feeling depressed or low 16 (10.0) 18 (11.25) 23 (14.38) 27 (16.88) 26 (16.25) 32 (20.0) 18 (11.25)
Fourth dimension: Social
19.  The restrictions your diabetes places on 
your family and friends
11 (6.88) 20 (12.5) 23 (14.38) 28 (17.50) 33 (20.63) 30 (18.75) 15 (9.38)
20.  Being embarrassed because you have 
diabetes
8 (5.0) 17 (10.63) 20 (12.50) 32 (20.0) 40 (25.0) 27 (16.88) 16 (10.0)
26.  Doing things that your family and friends 
do not do
18 (11.25) 22 (13.75) 19 (11.88) 27 (16.88) 33 (20.63) 26 (16.25) 15 (9.38)
37. Being identified as a diabetic 16 (10.0) 20 (12.50) 21 (13.13) 23 (14.38) 30 (18.75) 30 (18.75) 20 (12.50)
38.  Having diabetes interfere with your family 
life
16 (10.0) 18 (11.25) 25 (15.63) 28 (17.50) 28 (17.50) 29 (18.13) 16 (10.0)
Fifth dimension: Sexual behavior
21. Diabetes interfering with your sex life 36 (22.50) 29 (18.13) 20 (12.50) 21 (13.13) 28 (17.50) 16 (10.0) 10 (6.25)
23. Problems with sexual functioning 56 (35.0) 36 (22.50) 21 (13.13) 14 (8.75) 11 (6.88) 14 (8.75) 8 (5.0)
30. A decreased interest in sex 22 (13.75) 28 (17.50) 25 (15.63) 24 (15.0) 28 (17.50) 22 (13.75) 11 (6.88)
DM: Diabetes mellitus, D-39: Diabetes-39
Table 1: (Continued)
